Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (SENTIVUC II)

Rigshospitalet

Status: Enrolling

Conditions: Sentinel Lymph Node; Vulva Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT06161428

P-2022-946

Details and patient eligibility

About

The aim of the study is to evaluate the feasibility of applying the SLN mapping technique in combination with FDG-PET/CT imaging in women with vulva cancer tumour size >4 cm, multifocal tumors and local recurrences.

Enrollment: 100 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with vulva cancer, tumor > 4 cm, multifocal tumor, or local recurrences in vulva

Exclusion criteria

• Previous external irradiation of the vulva or groins
• Former sentinel node or inguinal lymphadenectomy in the relevant groin
• Known allergy to ICG or iodine
• Patient is in active treatment for other cancer and/or disseminated disease